z-logo
open-access-imgOpen Access
Cardiac Fibrosis Alleviated by Exercise Training Is AMPK-Dependent
Author(s) -
Xiuli Ma,
Yan Fu,
Han Xiao,
Yao Song,
Chen Ruifei,
Jing Shen,
Xiangbo An,
Qiang Shen,
Zijian Li,
Youyi Zhang
Publication year - 2015
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0129971
Subject(s) - ampk , protein kinase a , nadph oxidase , medicine , endocrinology , fibrosis , agonist , amp activated protein kinase , cardiac fibrosis , reactive oxygen species , chemistry , receptor , phosphorylation , oxidative stress , biochemistry
Regular exercise can protect the heart against external stimuli, but the mechanism is not well understood. We determined the role of adenosine monophosphate-activated protein kinase (AMPK) in regulating swimming exercise-mediated cardiac protection against β-adrenergic receptor overstimulation with isoproterenol (ISO) in mice. Ten-week-old AMPKα2 +/+ and AMPKα2-knockout (AMPKα2 -/- ) littermates were subjected to 4 weeks of swimming training (50 min daily, 6 days a week) or housed under sedentary conditions. The mice received daily subcutaneous injection of ISO (5 mg/kg/d), a nonselective β-adrenergic receptor agonist, during the last 2 weeks of swimming training. Swimming training alleviated ISO-induced cardiac fibrosis in AMPKα2 +/+ mice but not AMPKα2 -/- mice. Swimming training activated cardiac AMPK in AMPKα2 +/+ mice. Furthermore, swimming training attenuated ISO-induced production of reactive oxygen species (ROS) and expression of NADPH oxidase and promoted the expression of antioxidant enzymes in AMPKα2 +/+ mice but not AMPKα2 -/- mice. In conclusion, swimming training attenuates ISO-induced cardiac fibrosis by inhibiting the NADPH oxidase–ROS pathway mediated by AMPK activation. Our findings provide a new mechanism for the cardioprotective effects of exercise.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here